Allarity Therapeutics ALLR
NASDAQ ALLR
$1.06 +0.01 (+0.94%)
As of: Oct 1, 2026 · 2:31 PM EDT

Allarity Therapeutics (ALLR) Operating Interest Expenses (2023)

Updated

Allarity Therapeutics (ALLR) posted Operating Interest Expenses of $902,000 for FY2023.

Analysis

Allarity Therapeutics (ALLR) Operating Interest Expenses (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Interest Exp. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Allarity Therapeutics 1.69 Mn 1.69 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 526,000.00
Jun 30, 2023 367,000.00
Mar 31, 2023 9,000.00
API Access

Allarity Therapeutics Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-interest-expenses&ticker=ALLR&period=max&api_key=YOUR_API_KEY